Literature DB >> 12700175

Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients.

Sylvia G Lehmann1, Jean-Marie Wurtz, Jean-Paul Renaud, Paolo Sassone-Corsi, Enzo Lalli.   

Abstract

Mutations in the DAX-1 (NR0B1) gene cause the X-linked form of adrenal hypoplasia congenita (AHC), which is constantly found associated with hypogonadotropic hypogonadism (HHG). DAX-1 encodes an atypical orphan member of the nuclear hormone receptor superfamily. DAX-1 acts at multiple levels to repress the expression of genes involved in steroid hormone metabolism through a potent transcriptional repression domain present in its C-terminus, which is similar to the nuclear receptors' ligand binding domain. All DAX-1 mutations causing AHC/HHG alter the protein C-terminal domain, impairing its nuclear localization and, consequently, its transcriptional repression activity. Here we show that DAX-1 AHC mutants have a misfolded conformation, which correlates with their cytoplasmic retention. Extensive structure-function analysis reveals that the chemical nature of amino acid residues at positions interested by AHC mutations and critical determinants in helix 12 affect DAX-1 nuclear localization and transcriptional silencing. Surprisingly, mutations in a conserved putative corepressor binding surface have a negative effect upon DAX-1 transcriptional repression only when they also affect protein expression levels. These data suggest that a folding defect underlies the impaired function of DAX-1 missense mutants found in AHC/HHG patients and that interactions with transcriptional cofactors different from known corepressors mediate DAX-1 silencing properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700175     DOI: 10.1093/hmg/ddg108

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  10 in total

Review 1.  Hypogonadotropic hypogonadism in subjects with DAX1 mutations.

Authors:  Unmesh Jadhav; Rebecca M Harris; J Larry Jameson
Journal:  Mol Cell Endocrinol       Date:  2011-06-13       Impact factor: 4.102

2.  A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita.

Authors:  Imran Ahmad; Wendy F Paterson; Lin Lin; Peter Adlard; Philippa Duncan; John Tolmie; John C Achermann; Malcolm D C Donaldson
Journal:  Horm Res       Date:  2007-02-16

3.  Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization.

Authors:  Sylvia G Lehmann; Paolo Sassone-Corsi; Enzo Lalli
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

4.  E3 ubiquitin ligase RNF31 cooperates with DAX-1 in transcriptional repression of steroidogenesis.

Authors:  Anna Ehrlund; Elin Holter Anthonisen; Nina Gustafsson; Nicolas Venteclef; Kirsten Robertson Remen; Anastasios E Damdimopoulos; Anastasia Galeeva; Markku Pelto-Huikko; Enzo Lalli; Knut R Steffensen; Jan-Ake Gustafsson; Eckardt Treuter
Journal:  Mol Cell Biol       Date:  2009-02-23       Impact factor: 4.272

5.  ACTH-dependent precocious pseudopuberty in an infant with DAX1 gene mutation.

Authors:  Diego Yeste; Cristina González-Niño; Guiomar Pérez de Nanclares; Gustavo Pérez-Nanclares; Laura Audi; Luis Castaño; Antonio Carrascosa
Journal:  Eur J Pediatr       Date:  2008-04-15       Impact factor: 3.183

6.  The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1.

Authors:  Elena P Sablin; April Woods; Irina N Krylova; Peter Hwang; Holly A Ingraham; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-17       Impact factor: 11.205

7.  LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.

Authors:  Anita K Iyer; Yao-Hua Zhang; Edward R B McCabe
Journal:  Mol Genet Metab       Date:  2007-08-07       Impact factor: 4.797

8.  Identification and Functional Analysis of Six DAX1 Mutations in Patients With X-Linked Adrenal Hypoplasia Congenita.

Authors:  Chanisara Suthiworachai; Rachaneekorn Tammachote; Chalurmpon Srichomthong; Rungnapa Ittiwut; Kanya Suphapeetiporn; Taninee Sahakitrungruang; Vorasuk Shotelersuk
Journal:  J Endocr Soc       Date:  2018-12-12

Review 9.  EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma.

Authors:  Florencia Cidre-Aranaz; Javier Alonso
Journal:  Front Oncol       Date:  2015-07-20       Impact factor: 6.244

10.  Nonsense variant of NR0B1 causes hormone disorders associated with congenital adrenal hyperplasia.

Authors:  Da-Bei Fan; Li Li; Hao-Hao Zhang
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.